MOH engaging Great Eastern to better understand suspension of Mount Elizabeth pre-authorisation
GE's rationale was that high costs from the two named hospitals were the reason for this decision. PHOTO: ST FILE
SINGAPORE – The Ministry of Health (MOH) is engaging insurance group Great Eastern (GE) to better understand the impact of its decision to suspend pre-authorisation certificates for the Mount Elizabeth hospitals.
In its reply to queries from the media, MOH said Integrated Shield Plans (IPs) insurers 'would have to ensure that policyholders continue to be able to access the full benefits of their policies in accordance with the terms and conditions for claims, as stated in their policy contracts'.
GE, in a message to its panel doctors earlier this week, said it has temporarily stopped issuing pre-authorisation certificates from June 17 for policyholders admitted to Mount Elizabeth and Mount Elizabeth Novena hospitals.
Its rationale was that high costs from the two named hospitals, compared with other private hospitals, were the reason for this decision.
Pre-authorisation confirms that the insurer has approved the medical treatment, including the costs, before the treatment begins.
GE told its panel doctors the decision was not a reflection of their clinical quality, but the insurer was 'prioritising facilities that deliver the same high-quality care with greater cost transparency and cost-effectiveness'.
The decision took both the hospitals and GE policyholders by surprise.
In its e-mail to the media, MOH said the ability to afford major medical expenses is understandably a concern for Singaporeans and that all Singaporeans are covered by MediShield Life, which is sized to provide coverage for large subsidised bills.
'Singaporeans may opt to purchase IPs or additional coverage. As these are commercial products, while MOH regulates the key parameters of IPs for financial sustainability, individual insurers' changes to administrative processes such as pre-authorisation framework and partnerships with private providers are based on their commercial and actuarial considerations.'
The Straits Times has reached out to both GE and IHH Healthcare , which owns the Mount Elizabeth hospitals.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
a day ago
- CNA
Commentary: This health insurance clash is a chance to fix issues in Singapore's healthcare system
SINGAPORE: Tensions had been simmering for months, with insurer Great Eastern encouraging its panel doctors and agents to avoid Mount Elizabeth and Mount Elizabeth Novena hospitals and instead seek care elsewhere. Things came to a sudden head on Jun 17 when the insurer announced it was suspending pre-authorisation certificates at both hospitals, citing higher charges with no discernible differences in clinical outcomes. This was unprecedented in the decades-long history between healthcare payers and providers. It is a game-changing salvo in Singapore's healthcare landscape. Now, social media is awash with accusations of 'greedy' insurers and 'predatory' hospitals. Doctors and patients scramble to shift care to other facilities for fear of rejected claims later on. IHH, the operator of the two hospitals and by far the largest private healthcare group in Singapore, argued that the Mount Elizabeth Hospitals 'house facilities and equipment that allow specialists to manage patients and perform surgeries that are not available at other hospitals' and catered to more complex patients, thus justifying higher charges. The Ministry of Health (MOH) stated it was seeking clarification from Great Eastern, cautioning that the insurer must ensure 'policyholders continue to be able to access the full benefits of their policies in accordance with the terms and conditions for claims, as stated in their policy contracts'. What should we make of all this? There are two realities to recognise and two next steps to consider. HARD REALITIES OF SINGAPORE'S HEALTHCARE LANDSCAPE The first reality is the clear mutual dependence between insurers and private healthcare providers. Without private providers, there would be no need for private health insurance. Without private health insurance, many may not be able to afford private healthcare. That said, mutual dependence does not mean mutual interests. Insurers pool risk by collecting premiums from many to cover the claims of a smaller subset, but they cannot simply be passive conduits of our money without value-adding. They seek to optimise value for claims paid out, and managing the fees charged would be expected. Conversely, private sector doctors and facilities would seek to maximise fees and charges – within ethical boundaries – for example in opportunities to sell branded drugs instead of generics or use the latest equipment when the conventional would suffice for a good outcome. Doctors' fees, traditionally 50 per cent of the total bill, have been moderated after years of insurer interventions, such as encouraging use of panel doctors with pre-agreed fees or imposing fee guidelines. Facility fees, on the other hand, have largely escaped scrutiny and today can make up two-thirds of the total bill. It is unsurprising that insurers have now turned their attention to these. The second reality is that healthcare costs are rising unsustainably and left unchecked, this will be bad for everyone. The cost of healthcare insurance benefits – which is a useful proxy for private healthcare spending – has increased in Singapore by about 12 to 13 per cent every year in the last three years. Minister for Health Ong Ye Kung has stated that the government healthcare budget doubled in the last decade, jumping from S$9 billion in 2015 to S$21 billion this year and is projected to reach more than S$30 billion by 2030. BETTER PROTECTION FOR HEALTHCARE CONSUMERS Two actions taken in unison might help with the way forward. First, strengthen consumer protection. In the ongoing saga, it's surprising that policyholders have not publicly sought more reassurance from the insurer. While Great Eastern has said policyholders 'can still receive treatment and submit claims as usual with no impact to their benefits', customers may need to pay upfront and be reimbursed some time after receiving care in the affected hospitals. But they will be hardly reassured of their benefits, without knowing if there could be disputes over services rendered and fees. There should be, at least on an exceptional basis, an appeal process and mechanisms to enable pre-authorisation for patients with more complex needs, so the affected hospitals would still be accessible without worries about advance payments. Should people be allowed to freely switch insurers? Due to underwriting at enrolment, this is fraught with challenges (particularly if one has been diagnosed with a health condition) and is not realistic in practice. MOH said in November 2024 that it ' does not believe that mandating full portability for IPs is the right solution '. This leaves customers effectively captive with only two options: exiting private insurance with relying only on MediShield Life, or accepting new policy terms and premium increases, no matter how unjust these are perceived to be. Both are poor alternatives. The former further stresses an already stretched public healthcare system and increases current and future funding commitments by the government which it may struggle to honour in prolonged economic downturns. The latter worsens public frustration with 'Big Business' and risks fomenting the perception of an elitist government pandering to commercial ahead of citizens' interests. HELP PATIENTS MAKE BETTER DECISIONS Second, focus on data and transparency for decision-making. No two patients are the same. Hence to fairly compare across doctors and facilities, multiple other data points are collected for risk adjustment. Consider two surgeons each with a patient undergoing gallbladder removal surgery: One patient has kidney and heart issues and the other an otherwise healthy marathon runner. They would have very different care protocols and journeys, such as the need for post-operative intensive care, despite going through the same surgery. With appropriate risk adjustments, policymakers, insurers and healthcare providers can assess and compare the quality and cost-effectiveness of the surgeons and facilities despite them having very different patient profiles. Customers would really prioritise only three factors for healthcare services: clinical outcome, patient experience such as waiting time and service hospitality, and price. In choosing insurance products, beyond the current terms offered, customers would want to know the historic rates of declining claims, the number of disputes between insurer and policy holder as well as the patterns of premium adjustments over the years. MOH already puts out comparisons of insurers' lifetime premiums, sample contracts, claims processing duration and pre-authorisation turnaround times. Combining these with clinical data is necessary now. Surely in a Smart Nation, all this data could be collected, analysed and made available so that all stakeholders can make better decisions. We all want the best available for the lowest costs, and in finding value, such data would greatly aid customer selection of the insurers that best meet their needs and budgets. Different facilities do have different sophistication and expertise and these should be aligned to the needs of the specific patients. GOVERNMENT'S ROLE IN TRANSPARENCY The role of the government deserves re-examination. Singapore traditionally prefers light-touch regulation, opting for market mechanisms instead. Former health minister Khaw Boon Wan used to describe healthcare as the classic case of market failure and said that when the healthcare market fails, the government should explore how to step in to make the market work better as a first step. One condition for a perfect market is typically information transparency and the government has a role in enabling meaningful public availability of information. Strong government encouragement of both insurers and providers (doctors and facilities) to collect data in standardised manners and make it available is essential. Any data framework and analytics won't be perfect – especially when we first start, but anything would be better than the current 'he says, she says' situation with customers caught in the middle with no way of understanding whose arguments are founded. Facilitated negotiations would also help tremendously. MOH already has a regular platform to facilitate discussion across insurers, facilities and doctors on industry-wide issues. It is timely to ask how this can be made more effective, perhaps by involving the insurance regulator, the Monetary Authority of Singapore (MAS). A combined MOH-MAS team with expert knowledge and regulatory powers could convene the stakeholders to find effective solutions, without resorting to heavy-handed policy that could crush innovation and compel the industry into a downward spiral with only pricing as the differentiator. DON'T WASTE A 'GOOD CRISIS' The dispute between Great Eastern and IHH is a harbinger of worse things to come if this degenerates into a cesspool of misinformation and wild accusations. Yes, healthcare costs are escalating beyond society's ability to cope and effective solutions are needed. Yes, all parties seek and will need a fair profit to continue. But the public interest must be paramount. Insurers and healthcare providers need to recognise the mutual dependence despite divergent interests, and work together. Customer rights must also be better and more forcefully represented to balance the power of the insurers and providers. The government should step in to bring the disputing parties together in constructive dialogue and actionable solutions starting with better data, better analytics and better decision-making. The pragmatic Singapore way is not to waste a 'good crisis', but seize the opportunity to correct long-festering perversions in the current system. Else, patients and policyholders could get hurt while public confidence in both the healthcare and insurance sectors erodes, to the ultimate detriment of all of us. Jeremy Lim is a public health physician and author of Myth or Magic - The Singapore Healthcare System. Taufeeq Wahab is a doctor and senior preventive medicine resident with the National University Health System (NUHS).
Business Times
2 days ago
- Business Times
Swiss-American eye care firm Alcon launches expanded Tuas manufacturing facility
[SINGAPORE] Alcon, a Swiss-American pharmaceutical and medical device company specialising in eye care products, opened its expanded manufacturing and logistics facility in Tuas on Friday (Jun 27). This brings its total investment in Singapore to more than US$600 million since opening its first manufacturing site here in 2005. Located in Tuas Biomedical Park, the facility is one of Alcon's largest manufacturing sites, featuring advanced automation, smart manufacturing systems and industry 4.0 capabilities to support the increasing global demand for its contact lenses. It is also designed for operational efficiency and sustainability, with automation; digital systems; and features that reduce energy use, water consumption and waste. It has achieved zero waste to landfill and supports scalable production for global demand. Speaking at the launch event, Senior Minister of State for Trade and Industry Low Yen Ling said the partnership between Alcon and Singapore over the past 20 years exemplifies how deep, sustained collaboration can drive industrial growth and create meaningful careers for Singaporeans. 'Singapore is home to some of the world's best-in-class medtech manufacturing plants. The sector has been growing steadily, with a manufacturing output of S$19.4 billion in 2023, a nearly fourfold increase over the past decade,' she said. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up In a statement, Alcon said that the expansion is expected to create new 'high-value' jobs in areas such as manufacturing, quality control and distribution management. It will also support Singapore's ambition to grow its medtech workforce, which comprises over 400 companies and employs more than 16,000 people as of 2024. The company partners with local institutions and workforce programmes to build skills in precision engineering, biomedical sciences and artificial intelligence automation, supporting the growth of Singapore's medtech sector. One initiative is the Career Conversion Programme (CCP), which allowed the firm to tap into a broader, more diverse talent pool, including mid-career switchers and individuals seeking new roles. To date, nearly 180 associates have benefited. Muhammad Haiqal Sapuan, a beneficiary of the programme, worked in the oil and gas sector previously and joined Alcon as a senior technician in 2022. After participating in the CCP and undergoing strong mentoring, he now serves as an associate supervisor, leading a team of 15 in production technical operations. Alcon currently employs more than 25,000 people worldwide and serves over 260 million patients across 140 countries annually.
Straits Times
3 days ago
- Straits Times
Singapore pledges US$1m to global vaccine group Gavi
SINGAPORE - Singapore has pledged US$1 million ( S$1.3 million ) to global vaccine group Gavi as part of the country's continued commitment to global health and vaccine equity. The Ministry of Health (MOH) said on June 26 that the move reflects Singapore's support of efforts to bring life-saving vaccines to communities in need, especially in low-income countries. 'Vaccines are one of the most effective tools in preventing diseases and saving lives. However, millions of people around the world still lack access to essential vaccines,' said MOH. 'Gavi bridges these gaps by working with governments, international organisations, and private sector partners to deliver vaccines to underserved populations. It also plays a pivotal role in enhancing pandemic preparedness, improving immunisation systems and ensuring equitable access to vaccines during global health emergencies.' In June, Gavi said it was seeking new donors for its work funding childhood immunisation in the world's poorest countries. It aimed to raise US$9 billion of its total requirement of US$11.9 billion at a summit in Brussels on June 26 for its work from 2026-2030. In a Facebook post on June 26 , Gavi's chief executive Sania Nishtar said that Gavi had received more than US$9 million pledges from a record number of donors, which she said would protect 500 million children that the group aims to vaccinate over the next five years. Gavi is currently focused on combating a global measles outbreak and is responding to cholera outbreaks in Sudan, South Sudan, and Angola, where it has made special arrangements to supply vaccines from its stockpiles, and is also supporting Sierra Leone, where the spread of mpox has accelerated. In a video message to the Gavi Global Summit on June 26, Singapore's health minister Ong Ye Kung lauded Gavi's 'pivotal' role in the global response to the Covid-19 pandemic, describing it as a 'monumental achievement, demonstrating the power of solidarity and the critical importance of investing in global health infrastructure'. However, he noted that Gavi faced its share of criticism, that it could have done more and that it could not totally eradicate vaccine inequality between economies. 'Sometimes it is not easy to be on the side of good. It takes courage and a strong sense of mission and purpose. Gavi has done this, and it deserves our strong support,' said Mr Ong. Singapore first became a Gavi donor in 2020 during the Covid-19 pandemic, contributing US$5 million to Gavi's Advance Market Commitment, which is a mechanism under the Covid-19 Vaccine Global Access Facility ensuring access to Covid-19 vaccines and support for lower-income countries . The Trump administration has previously indicated that it planned to cut its funding for Gavi, representing around US$300 million annually, which risks causing more than a million deaths, according to Ms Nishtar. Join ST's WhatsApp Channel and get the latest news and must-reads.
